Medrogestone (BioDeep_00000180704)
human metabolite blood metabolite
代谢物信息卡片
化学式: C23H32O2 (340.2402)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC(=O)C1(C)CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC12C
InChI: InChI=1S/C23H32O2/c1-14-12-17-18(21(3)9-6-16(25)13-20(14)21)7-11-23(5)19(17)8-10-22(23,4)15(2)24/h12-13,17-19H,6-11H2,1-5H3
描述信息
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03D - Progestogens > G03DB - Pregnadien derivatives
D000970 - Antineoplastic Agents
同义名列表
11 个代谢物同义名
14-acetyl-2,8,14,15-tetramethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-6,8-dien-5-one; Solvay brand OF medrogestone; Biodim brand OF medrogestone; Wyeth brand OF medrogestone; Medrogestone biodim brand; Medrogestone solvay brand; Medrogestone wyeth brand; Medrogestone; Colprone; Prothil; Colpro
数据库引用编号
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
亚细胞结构定位 | 关联基因列表 |
---|
文献列表
- Christina Piperi, Michael Tzivras, Christos Kalofoutis, Aikaterini Skenderi, Vasiliki Michalaki, Anastasios Kalofoutis. Effects of hormone replacement therapy on the main fatty acids of serum and phospholipids of postmenopausal women.
In vivo (Athens, Greece).
2005 Nov; 19(6):1081-5. doi:
NULL
. [PMID: 16277026] - Christian Jamin, Christophe Poncelet, Patrick Madelenat. [Tibolone].
Presse medicale (Paris, France : 1983).
2002 Sep; 31(28):1314-22. doi:
"
. [PMID: 12355994] - Inka Wiegratz, Franz Starflinger, Wolfgang Tetzloff, Beate Leifels-Fischer, Frans A Helmond, Jeanne S E Dericks-Tan, Herbert Kuhl. Effect of tibolone compared with sequential hormone replacement therapy on carbohydrate metabolism in postmenopausal women.
Maturitas.
2002 Feb; 41(2):133-41. doi:
10.1016/s0378-5122(01)00278-x
. [PMID: 11836044] - Somnuek Domrongkitchaiporn, Boonsong Ongphiphadhanakul, Wasana Stitchantrakul, Sirinthorn Chansirikarn, Gobchai Puavilai, Rajata Rajatanavin. Risk of calcium oxalate nephrolithiasis in postmenopausal women supplemented with calcium or combined calcium and estrogen.
Maturitas.
2002 Feb; 41(2):149-56. doi:
10.1016/s0378-5122(01)00277-8
. [PMID: 11836046] - C A Aguilar-Salinas, O Arita Melzer, L Sauque Reyna, A Lopez, M L Velasco Perez, L E Guillen, F J Gomez Perez, J A Rull Rodrigo. Effects of estrogen/medrogestone therapy on the apoprotein B-containing lipoproteins in postmenopausal women with type 2 diabetes mellitus under satisfactory and non-satisfactory glycemic control.
The Israel Medical Association journal : IMAJ.
2001 Feb; 3(2):137-43. doi:
"
. [PMID: 11344825] - J Belaisch, C Nappi, P Affinito, H De Gezelle, M Botelho, H M Oliveira, J Martinez-Oliveira, F Gonzaga. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
Journal de gynecologie, obstetrique et biologie de la reproduction.
2000 Feb; 29(1):29-40. doi:
. [PMID: 10675831]
- N Taechakraichana, K Limpaphayom, T Ninlagarn, K Panyakhamlerd, S Chaikittisilpa, N Dusitsin. A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women.
Obstetrics and gynecology.
2000 Jan; 95(1):87-94. doi:
10.1016/s0029-7844(99)00493-7
. [PMID: 10636509] - D Foth, T Römer, A Benthin. [Parameters of lipid metabolism in postmenopausal women on oral or transdermal hormone replacement with or without progesterone].
Zentralblatt fur Gynakologie.
2000; 122(9):483-8. doi:
10.1055/s-2000-10612
. [PMID: 11050765] - C Clemente, M G Caruso, P Berloco, M Notarnicola, B D'Attoma, A R Osella, V Guerra, A Buonsante, B Giannandrea, A Di Leo. Antioxidant effect of short-term hormonal treatment in postmenopausal women.
Maturitas.
1999 Jan; 31(2):137-42. doi:
10.1016/s0378-5122(98)00088-7
. [PMID: 10227007] - M Sillem, M Parviz, H W Woitge, L Kiesel, U Ulrich, T von Holst, B Runnebaum, R Ziegler, M J Seibel. Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
1999; 107(6):379-85. doi:
10.1055/s-0029-1212129
. [PMID: 10543415] - W J Lin, S J Her, P F Chen, R R Chen. Determination of medrogestone in plasma by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications.
1998 Sep; 714(2):263-8. doi:
10.1016/s0378-4347(98)00223-0
. [PMID: 9766865] - C Egarter, P Geurts, E Boschitsch, P Speiser, J Huber. The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women.
Acta obstetricia et gynecologica Scandinavica.
1996 Apr; 75(4):386-93. doi:
10.3109/00016349609033337
. [PMID: 8638462] - J A Gevers Leuven, M J van der Mooren, R Buytenhek. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
Fertility and sterility.
1995 Sep; 64(3):525-31. doi:
10.1016/s0015-0282(16)57787-5
. [PMID: 7641905] - B C Hennis, D I Boomsma, K Fijnvandraat, J A Gevers Leuven, M Peters, C Kluft. Estrogens reduce plasma histidine-rich glycoprotein (HRG) levels in a dose-dependent way.
Thrombosis and haemostasis.
1995 Mar; 73(3):484-7. doi:
10.1055/s-0038-1653801
. [PMID: 7667832] - G Strauch, P Perles, J P Tresca, M Letrait, I Broudic, J Delchambre. [Ovulation inhibition with medrogestone administered on the 4th through the 24th day of the cycle].
Contraception, fertilite, sexualite (1992).
1994 Nov; 22(11):705-8. doi:
NULL
. [PMID: 7820191] - M J van der Mooren, J A Leuven, R Rolland. Effect of conjugated estrogens with and without medrogestone: a prospective study.
Maturitas.
1994 May; 19(1):33-42. doi:
10.1016/0378-5122(94)90039-6
. [PMID: 7935030] - L Dehennin. Quantification of medrogestone in serum by isotope dilution mass spectrometry.
Clinical chemistry.
1993 Nov; 39(11 Pt 1):2353-4. doi:
10.1093/clinchem/39.11.2353
. [PMID: 8222244] - P Affinito, G A Tommaselli, R Morgera, M Rinaldi, P Di Mauro, C Nappi. [Continuous postmenopausal estrogen-progesterone therapy].
Minerva ginecologica.
1993 Mar; 45(3):77-85. doi:
NULL
. [PMID: 8392669] - W Haenggi, M H Birkhaeuser. A new peroral estrogen/progestin combination for postmenopausal hormonal substitution: an open multicentric field study.
Maturitas.
1993 Mar; 16(2):111-22. doi:
10.1016/0378-5122(93)90055-m
. [PMID: 8387150] - E W Sonnendecker, E S Polakow, A J Benadé, E Simchowitz. Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women.
American journal of obstetrics and gynecology.
1989 May; 160(5 Pt 1):1128-34. doi:
10.1016/0002-9378(89)90174-9
. [PMID: 2543223] - A T Teichmann, H Wieland, P Cremer, B Hinney, W Kuhn, D Seidel. Effects of medrogestone and conjugated oestrogens on serum lipid and lipoprotein concentrations.
Maturitas.
1985 Nov; 7(4):343-50. doi:
10.1016/0378-5122(85)90058-1
. [PMID: 3001482] - H Lübbert, K Pollow, A Römmler, J Hammerstein. Estradiol and progesterone receptor concentrations and 17 beta-hydroxysteroid-dehydrogenase activity in estrogen-progestin stimulated endometrium of women with gonadal dysgenesis.
Journal of steroid biochemistry.
1982 Aug; 17(2):143-8. doi:
10.1016/0022-4731(82)90113-3
. [PMID: 6810024] - A Schoenenberger, D Hauri. [Conservative treatment of benign prostatic hyperplasia (author's transl)].
Therapeutische Umschau. Revue therapeutique.
1982 Apr; 39(4):260-7. doi:
"
. [PMID: 6179177] - C Auclair, M L Givner. Medrogestone and an LHRH analogue as potential combination therapy for hormone-dependent cancers.
Archives of andrology.
1982 Feb; 8(1):21-4. doi:
10.3109/01485018208987013
. [PMID: 7039538] - E W Sonnendecker, E S Polakow, L Gerdes. Psycho-endocrine differences and correlations in symptomatic and asymptomatic climacteric women - the possible role of prolactin.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
1981 Oct; 60(17):661-5. doi:
NULL
. [PMID: 6272429] - R G Frith, G Phillipou. Measurement of plasma progesterone and its O-methyloxime by gas chromatography-nitrogen detection.
Annals of clinical biochemistry.
1981 Mar; 18 (Pt 2)(?):84-7. doi:
10.1177/000456328101800205
. [PMID: 7259074] - W T Robinson, L Cosyns. Medrogestone: analysis in serum by high-pressure liquid chromatography.
Arzneimittel-Forschung.
1979; 29(6):882-5. doi:
NULL
. [PMID: 582778] - S D Stroupe, U Westphal. Alterations in the ultraviolet absorption spectra of steroids upon binding to serum proteins.
Biochemistry.
1978 Mar; 17(5):882-7. doi:
10.1021/bi00598a021
. [PMID: 75741] - S D Stroupe, U Westphal. Steroid-protein interactions. Stopped flow fluorescence studies of the interaction between steroid hormones and progesterone-binding globulin.
The Journal of biological chemistry.
1975 Nov; 250(22):8735-9. doi:
. [PMID: 171262]
- G Sufrin, D S Coffey. Differences in the mechanism of action of medrogestone and cyproterone acetate.
Investigative urology.
1975 Jul; 13(1):1-9. doi:
NULL
. [PMID: 1140913] - D F Paulson, R D Kane. Medrogestone: a prospective study in the pharmaceutical management of benign prostatic hyperplasia.
The Journal of urology.
1975 Jun; 113(6):811-5. doi:
10.1016/s0022-5347(17)59585-3
. [PMID: 1097740] - H Selye, S Szabo, Y Taché, P Kourounakis, I Mécs I+MECS, J Taché J+TACHE. Effect of glucocorticoids upon resistance to various toxicants.
Steroids and lipids research.
1974; 5(1):10-22. doi:
NULL
. [PMID: 4418494]